Independent Investment Research (IIR) releases independent report on Chatham Rock Phosphate

Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Independent Investment Research (IIR) releases independent report on Chatham Rock Phosphate

Canada NewsWire

WELLINGTON, New Zealand, Oct. 18, 2017 /CNW/ - Today Australia based Independent Investment Research released an independent research report on Chatham Rock Phosphate to its extensive international client list. The report has also been published on the Bloomberg, Reuters, FactSet, Capital IQ and Research Tree (UK) platforms 

A summary of the report follows. The full report can be accessed from IIR (see link below), is available from me on request, and is also accessible at    

For and on behalf of the Board,

Chris Castle
Chief Executive Officer
Chatham Rock Phosphate Limited
64 21 55 81 85 or [email protected]

Neither the Exchange, its Regulation Service Provider (as that term is defined under the policies of the Exchange), or New Zealand Exchange Limited has in any way passed upon the merits of the Transaction and associated transactions, and has neither approved nor disapproved of the contents of this press release.



Metals & Mining

Chatham Rock Phosphate (TSXV:NZP, NZAX:CRP, FSE:3GRE) 

Initiation of Coverage  


Chatham Rock Phosphate Limited ("CRP" or "the Company") is working towards a planned 2022 start of production from its 100% owned offshore Chatham Rise Phosphate Project ("CRPP" or "the Project"), located in ~400m of water on the Chatham Rise, some 450km east of Christchurch in New Zealand.

The current resource, estimated to contain some 24.3 Mt of high quality phosphorite nodules, with an estimated grade of 21.5% to 22% P2O5, is sufficient to support a 15 year, 1.5 mtpa operation, with significant resource upside. The Company is currently working towards a late 2018 submittal of a re-application for the "Marine Consents" environmental approval, with a 20 year Mining Licence previously granted in 2013. 


Low capex operation: The development strategy is to develop the Project using contract mining/dredging, to obviate the requirement to raise and spend the significant capital required to buy and fit out a suitable dredge. To that end, the Company has worked closely with Netherlands based Boskalis Offshore Subsea Contracting B.V. ("Boskalis"), one of the largest dredging companies globally, who is also the technical partner on the CRPP. The planned vessel also includes on-ship processing, resulting in ports being the only required onshore facilities. 

Ready access to ports: To that end the Project is located within 500km of five New Zealand ports with the capability of handling the planned vessel; of these four have dry bulk material handling facilities, with the only expected cost to the Company being handling charges on a per tonne operating basis. 

Strong financial metrics: Given the above, and using current estimated revenues and operating costs, the CRPP has the potential to provide ~US$41 million/year in free cash flow to CRP, and an average annual EBITDA of US$58 million

Quality resource: Work to date has highlighted the quality of the CRPP phosphate, in being a highly reactive phosphate rock ("RPR"), suitable for most applications, including being used to produce single superphosphate ("SSP"), and being suitable for direct application as a substitute for both SSP and triple superphosphate ("TSP") - this quality is supported by the results of agronomic work to date. 

Low contaminants: A key feature of the Chatham Rise phosphate is the low level of toxic elements, in particular cadmium; the EU is in the process of legislating lower levels of cadmium in phosphate fertilisers, which will preclude supply from current major producing areas and thus increase demand for the cleaner products. 

Supportive shareholders: Recent capital raisings have seen the entry of cornerstone investors from Switzerland, Germany and Singapore, with representatives being appointed to the board; the cornerstones hold some 30% of CRP, with the other Board members holding an additional 10%, thus aligning their interests with those of other shareholders. 

Stable, mining jurisdiction: New Zealand is a stable mining jurisdiction, having a long history of mining for various commodities. 

Well leveraged to success: With a market capitalisation of ~C$7 million CRP is well leveraged to positive news flow. 


As of June 30, 2017, the Company had C$0.779 million in free cash and no debt. 

CRP also has restricted cash of C$0.481 million, held in trust and representing approximately 64% of an unpaid amount claimed by the EPA currently in dispute with the Company. 

There are currently ~1.5 million in the money warrants on issue with the potential to bring in C$560k in cash if exercised. 

Over the fifteen months to June 30, 2017, the Company spent C$1.526 million on operating activities. 

Over the same period the Company has raised C$2.656 million after costs, with the most recent raising being a brokered private placement of C$0.442 million, through the issue of 884,587 units each consisting of one C$0.50 ordinary share and half a two year warrant with an exercise price of C$1.00

The Company has announced that it expects to have to raise an additional US$14.14 million over the next three years largely to fund activities related to project permitting, which will include offshore activities.


CRP currently has 14,988,184 fully paid ordinary shares on issue. 

The Company underwent a 10 for 1 consolidation in March 2017, concurrent with listing on the TSX Venture Exchange. 

Warrants on issue include 1,524,618 discretionary warrants with an exercise price of C$0.366 before March 17, 2018, and 442,294 warrants with an exercise price of C$1.00 before June 28, 2019 - the latest warrants were issued as part of the latest capital raising. 

Cornerstone investors hold ~30%, with Board and Management, not including the cornerstone investors or their representatives on the Board, holding an additional ~10%. 

The Top 20 shareholders hold 57.79%. 

CRP has ~1,500 shareholders. 


Our research presents in tabular form the various ASX and TSX listed phosphate developers with published resources. 

We have converted AUD denominated share prices and market capitalisations to CAD at a 1:1 exchange rate. 

CRP is the only listed phosphate company with an offshore project - the only other offshore phosphate project is the Sandpiper Project owned by Namibia Marine Phosphate, a private company majority held by Mawarid Mining of Oman. 

What our research highlights is the relatively low market capitalisation of CRP, and the uplift potential with project de-risking as compared to its peers globally in the sector. 


We have completed a risked DCF valuation for CRP, with this presented in a tabular form in our research report. This is a base case valuation, with significant upside on de-risking, particularly with grant of the Marine Consents. The per share valuation is based on the current share structure diluted for raisings of US$14.14 million as flagged by the Company.  We would expect this risked base case valuation of C$1.64/share to increase as the project is advanced and de-risked - a critical driver of value will be the approval of the "Marine Consents". 

Full Report 

Only recipients of this email can access the full report for gratis from our website or  request for the full copy of the report from [email protected]. You may have already received our note via our platform recently - if so, you can elect to unsubscribe below.

Kind regards,
Caroline Elton, Head of Distribution & Investor Platforms



General inquiries:

Level 1, 350 George Street, SYDNEY NSW 2000

Level 7, 20-22 Albert Road, South MELBOURNE VIC 3205

200 Quebec Street, 300 - 111 DENVER, CO 80230, USA

1303 COFCO Tower, Gloucester Road, Causeway Bay, HONG KONG

Telephone Enquiries: +61 2 8001 6693

Email inquiries:
[email protected]

Independent Investment Research - Sydney & Melbourne

If you wish not be on our mailing list please click on unsubscribe below

Preferences  |  Unsubscribe

SOURCE Chatham Rock Phosphate

View original content:

Copyright CNW Group 2017

Comment On!

Upload limit is up to 1mb only
To post messages to your Socail Media account, you must first give authorization from the websites. Select the platform you wish to connect your account to (via Easy Blurb).